HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis

医学 内科学 危险系数 荟萃分析 肝细胞癌 肝硬化 阶段(地层学) 置信区间 队列研究 随机对照试验 生物 古生物学
作者
Amit G. Singal,Emily Zhang,Manasa Narasimman,Nicole E. Rich,Akbar K. Waljee,Yujin Hoshida,Ju Dong Yang,María Reig,Giuseppe Cabibbo,Pierre Nahon,Neehar D. Parikh,Jorge A. Marrero
出处
期刊:Journal of Hepatology [Elsevier BV]
卷期号:77 (1): 128-139 被引量:187
标识
DOI:10.1016/j.jhep.2022.01.023
摘要

•HCC surveillance was associated with improved early-stage detection, curative treatment receipt, and prolonged survival.•Semi-annual surveillance intervals were associated with improved early HCC detection and overall survival.•Few studies evaluated surveillance outcomes in post-SVR or NAFLD patient populations; thus, future research is warranted.•Few studies characterized surveillance-related harms, although available data suggest surveillance harms are mild in severity. Background & AimsThere is controversy regarding the overall value of hepatocellular carcinoma (HCC) surveillance in patients with cirrhosis given the lack of data from randomized-controlled trials. To address this issue, we conducted a systematic review and meta-analysis of cohort studies evaluating the benefits and harms of HCC surveillance in patients with cirrhosis.MethodsWe performed a search of the Medline and EMBASE databases and national meeting abstracts from January 2014 through July 2020 for studies reporting early-stage HCC detection, curative treatment receipt, or overall survival, stratified by HCC surveillance status, among patients with cirrhosis. Pooled risk ratios (RRs) and hazard ratios, according to HCC surveillance status, were calculated for each outcome using the DerSimonian and Laird method for random effects models.ResultsWe identified 59 studies including 145,396 patients with HCC, which was detected by surveillance in 41,052 (28.2%) cases. HCC surveillance was associated with improved early-stage detection (RR 1.86, 95% CI 1.73–1.98; I2 = 82%), curative treatment receipt (RR 1.83, 95% CI 1.69–1.97; I2 = 75%), and overall survival (hazard ratio 0.67, 95% CI 0.61–0.72; I2 = 78%) after adjusting for lead-time bias; however, there was notable heterogeneity in all pooled estimates. Four studies examined surveillance-related physical harms due to false positive or indeterminate surveillance results, but no studies examined potential financial or psychological harms. The proportion of patients experiencing surveillance-related physical harms ranged from 8.8% to 27.5% across studies, although most harms were mild in severity.ConclusionHCC surveillance is associated with improved early detection, curative treatment receipt, and survival in patients with cirrhosis, although there was heterogeneity in pooled estimates. Available data suggest HCC surveillance is of high value in patients with cirrhosis, although continued rigorous studies evaluating benefits and harms are still needed.Lay summaryThere has been ongoing debate about the overall value of hepatocellular carcinoma (HCC) screening in patients with cirrhosis given the lack of data from randomized-controlled trials. In a systematic review of contemporary cohort studies, we found that HCC screening is associated with improved early detection, curative treatment receipt, and survival in patients with cirrhosis, although there were fewer data quantifying potential screening-related harms. Available data suggest HCC screening is of high value in patients with cirrhosis, although continued studies evaluating benefits and harms are still needed. There is controversy regarding the overall value of hepatocellular carcinoma (HCC) surveillance in patients with cirrhosis given the lack of data from randomized-controlled trials. To address this issue, we conducted a systematic review and meta-analysis of cohort studies evaluating the benefits and harms of HCC surveillance in patients with cirrhosis. We performed a search of the Medline and EMBASE databases and national meeting abstracts from January 2014 through July 2020 for studies reporting early-stage HCC detection, curative treatment receipt, or overall survival, stratified by HCC surveillance status, among patients with cirrhosis. Pooled risk ratios (RRs) and hazard ratios, according to HCC surveillance status, were calculated for each outcome using the DerSimonian and Laird method for random effects models. We identified 59 studies including 145,396 patients with HCC, which was detected by surveillance in 41,052 (28.2%) cases. HCC surveillance was associated with improved early-stage detection (RR 1.86, 95% CI 1.73–1.98; I2 = 82%), curative treatment receipt (RR 1.83, 95% CI 1.69–1.97; I2 = 75%), and overall survival (hazard ratio 0.67, 95% CI 0.61–0.72; I2 = 78%) after adjusting for lead-time bias; however, there was notable heterogeneity in all pooled estimates. Four studies examined surveillance-related physical harms due to false positive or indeterminate surveillance results, but no studies examined potential financial or psychological harms. The proportion of patients experiencing surveillance-related physical harms ranged from 8.8% to 27.5% across studies, although most harms were mild in severity. HCC surveillance is associated with improved early detection, curative treatment receipt, and survival in patients with cirrhosis, although there was heterogeneity in pooled estimates. Available data suggest HCC surveillance is of high value in patients with cirrhosis, although continued rigorous studies evaluating benefits and harms are still needed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhaohu47完成签到,获得积分10
1秒前
超帅鸭子发布了新的文献求助10
1秒前
每每反完成签到,获得积分10
3秒前
凡凡完成签到 ,获得积分10
4秒前
5秒前
呆鹅喵喵完成签到,获得积分10
5秒前
忧心的洙完成签到,获得积分10
6秒前
123完成签到,获得积分10
6秒前
青青草完成签到,获得积分10
8秒前
Fang Xianxin完成签到,获得积分20
8秒前
yue发布了新的文献求助10
8秒前
小甘看世界完成签到,获得积分0
10秒前
量子星尘发布了新的文献求助10
10秒前
张今天也要做科研呀完成签到,获得积分10
11秒前
nater3ver完成签到,获得积分10
12秒前
12秒前
自然怀梦完成签到,获得积分10
12秒前
轻歌水越完成签到 ,获得积分10
12秒前
执意完成签到 ,获得积分10
13秒前
大模型应助Coral采纳,获得10
13秒前
songyl完成签到,获得积分10
14秒前
怡然问晴发布了新的文献求助20
15秒前
24K纯帅完成签到,获得积分0
15秒前
LL发布了新的文献求助20
15秒前
飒飒发布了新的文献求助10
17秒前
JamesPei应助幸福广山采纳,获得10
18秒前
莫封叶完成签到,获得积分10
18秒前
iiiau完成签到,获得积分10
19秒前
ersan发布了新的文献求助10
19秒前
小蘑菇完成签到,获得积分10
20秒前
Loooong应助李cc采纳,获得10
20秒前
单纯乞完成签到,获得积分10
20秒前
20秒前
赘婿应助科研通管家采纳,获得10
21秒前
NexusExplorer应助科研通管家采纳,获得10
21秒前
21秒前
搜集达人应助科研通管家采纳,获得10
21秒前
打打应助科研通管家采纳,获得10
21秒前
Mars应助科研通管家采纳,获得10
21秒前
21秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038303
求助须知:如何正确求助?哪些是违规求助? 3576013
关于积分的说明 11374210
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029